A US Food and Drug Administration (FDA) investigation of injection-site necrosis in some people who received the 23-valent pneumococcal vaccine has concluded that the benefits of the vaccine outweigh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback